Search Within

Genitourinary Oncology Service

Formats
  1. Journal Article (2795)
  2. Meeting Abstract (2525)
  3. Review (121)
  4. Book Section (83)
  5. Editorial (57)
  6. Correspondence (34)
  7. Conference Paper (29)
  8. Guidelines (25)
  9. Research Letter (18)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Solid Tumor Oncology Division (5695)
  2. Department of Medicine (5685)
  3. GSK Faculty (1658)
  4. Human Oncology and Pathogenesis Program (1157)
  5. Department of Pathology and Laboratory Medicine (1129)
  6. Surgery (1021)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. David Solit (785)
  4. Dean Bajorin (664)
  5. Michael Morris (588)
  6. Jonathan Rosenberg (525)

More People

Years
  1. 2025 (203)
  2. 2024 (294)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1713)
  2. Annals of Oncology (304)
  3. Clinical Cancer Research (283)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (123)

More Publications

Publishers
  1. American Society of Clinical Oncology (1780)
  2. American Association for Cancer Research (689)
  3. Oxford University Press (414)
  4. Elsevier Science, Inc. (396)
  5. Elsevier Inc. (380)
  6. Nature Publishing Group (304)

More Publishers

Results (5695)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Progression of RAS-mutant leukemia during RAF inhibitor treatment
    Journal Article

    Callahan, M. K.; Rampal, R.; Harding, J. J.; Klimek, V. M.; Chung, Y. R.; Merghoub, T.; Wolchok, J. D.; Solit, D. B.; Rosen, N.; Abdel-Wahab, O.; more...
    New England Journal of Medicine (2012)

    Fulltext@MSK | Save
  • Practical use of perioperative chemotherapy for muscle-invasive bladder cancer: Summary of session at the Society of Urologic Oncology annual meeting
    Journal Article

    Apolo, A. B.; Grossman, H. B.; Bajorin, D.; Steinberg, G.; Kamat, A. M.
    Urologic Oncology: Seminars and Original Investigations (2012)

    Fulltext@MSK | Save
  • ARN-509 in men with high risk non-metastatic castration-resistant prostate cancer
    Meeting Abstract

    Smith, M. R.; Antonarakis, E. S.; Ryan, C. J.; Berry, W.; Shore, N. D.; Liu, G.; Alumkal, J.; Higano, C.; Chow-Maneval, E.; Rathkopf, D.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Association of baseline corticosteroid with outcomes in a multivariate analysis of the phase 3 AFFIRM study of enzalutamide (ENZA), an androgen receptor signaling inhibitor (ARSI)
    Meeting Abstract

    Scher, H. I.; Fizazi, K.; Saad, F.; Chi, K.; Taplin, M.; Sternberg, C. N.; Armstrong, A. J.; Hirmand, M.; Selby, B.; de Bono, J. S.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Association of radiographic progression-free survival (rPFS) adapted from Prostate Cancer Working Group 2 (PCWG2) consensus criteria (APCWG2) with overall survival (OS) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results from COU-AA-302
    Meeting Abstract

    Ryan, C. J.; Morris, M.; Molina, A.; Piulats, J. R.; De Souza, P.; Li, J.; Kheoh, T.; de Bono, J. S.; Larson, S.; Griffin, T.; more...
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Genes, chromosomes and the treatment of bladder cancer
    Meeting Abstract

    Rosenberg, J. E.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Sunitinib treatment of renal adjuvant cancer (S-TRAC): A randomized, double-blind, phase III study of sunitinib vs. placebo in subjects at high risk of recurrent renal cell carcinoma (RCC)
    Meeting Abstract

    Ravaud, A.; Motzer, R. J.; Pandha, H.; Staehler, M.; George, D. J.; Pantuck, A.; Patel, A.; Gerletti, P.; Chen, L.; Patard, J.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • ARN-509 in men with metastatic castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Rathkopf, D.; Antonarakis, E. S.; Shore, N. D.; Tutrone, R.; Alumkal, J.; Ryan, C. J.; Saleh, M.; Hauke, R.; Chow-Maneval, E.; Scher, H. I.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Biomarkers of everolimus efficacy in patients with metastatic renal cell carcinoma (mRCC): Analysis of the phase III RECORD-1 trial
    Meeting Abstract

    Oudard, S.; Escudier, B.; Thompson, J.; Grünwald, V.; Conte, P. F.; Bracarda, S.; Panneerselvam, A.; Gogov, S.; Chen, D.; Motzer, R. J.
    Annals of Oncology (2012)

    Fulltext@MSK | Save
  • Tivozanib pharmacokinetic (PK)/pharmacodynamic (PD) analysis of blood pressure (BP) and soluble vascular endothelial growth factor receptor 2 (sVEGFR2) in patients with advanced renal cell carcinoma (RCC)
    Meeting Abstract

    Nosov, D.; Motzer, R. J.; Loewy, J.; Hodge, L.; Esteves, B.; Berkenblit, A.; Yin, W.; Dykstra, K.; Hutson, T. E.; Cotreau, M.
    Annals of Oncology (2012)

    Fulltext@MSK | Save